LFA Antibody testing

NordicDx – FarmDx – AquaDx

The capabilities of NordicDx extend beyond human healthcare and into the sectors of aquaculture and livestock health. We utilize advanced technologies like Lateral Flow Assay (LFA) and innovative devices such as our iaX LFA reader to perform diagnostic tests.

As an example of our capabilities, we offer a rapid, in-vitro diagnostic test that detects antibodies from COVID-19 infections or vaccinations.

This test, which identifies the presence of antibodies against SARS-CoV-2, the virus that causes COVID-19, is not limited to this application. The core technology can be developed and adapted to monitor the antibody status of livestock and fish throughout their lifespan. The technology enables early detection and mitigation of health issues, contributing to the overall well-being of these animals and fish and, ultimately, to the productivity and sustainability of these industries.

Our iaX LFA reader plays a crucial role in this process. It can interpret test results in seconds, quantitatively measuring antibody levels. This device, backed by a cloud-based system, facilitates real-time monitoring and data analysis worldwide. It’s not just about knowing if an animal or fish has antibodies against a certain pathogen, but also understanding the concentration of these antibodies and monitoring how these changes over time.

Our technologies have a broad spectrum of potential applications. We invite you to contact us if you see a potential application for your work within aquaculture or livestock farming or wish to learn more about our products and services. NordicDx is eager to explore possible cooperation and adapt our technologies to meet the specific needs of your operations. Let’s work together to improve animal health and industry productivity.